Clinical trial

Treatment With Lorcaserin for Cocaine Use: The TLC Study

NCT03192995

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-01-01

PhasePHASE2

Study timeline

Study start (actual)2018-01-01Date precision: day

Registry last updated2023-08-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cocaine Use Disorderunresolved

Interventions

Placebo Oral TabletDRUG

Substance use counselingBEHAVIORAL

ACASIBEHAVIORAL

Cocaine metabolitesDIAGNOSTIC_TEST

Ecological Momentary Assessment (EMA)BEHAVIORAL

Balloon Analogue Risk Task (BART)BEHAVIORAL

Qualitative Exit InterviewBEHAVIORAL

Sponsors & collaborators

Glenn-Milo Santoslead sponsor

National Institute on Drug Abuse (NIDA)collaborator

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03192995 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.